Ind-Swift Limited Price (INDSWFTLTD.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

54,164,653

(0)%

Ind-Swift Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nut... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $13.03-34.7
  • Market Cap 744.22M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Dr. Gopal Munjal M.D.
  • IPO Date: October, 18, 2004
  • Country: IN
  • Currency: INR
  • Headquaters: No Data
  • Employees: 1054

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation